107 related articles for article (PubMed ID: 23046493)
21. Chemoembolization-induced arterial damage: Evaluation of three different chemotherapeutic protocols using epirubicin and miriplatin.
Iwazawa J; Hashimoto N; Ohue S; Muramoto O; Mitani T
Hepatol Res; 2014 Feb; 44(2):201-8. PubMed ID: 23551984
[TBL] [Abstract][Full Text] [Related]
22. Angiographic Evaluation of Vascular Damage in Rat Liver After Administration of Epirubicin or Miriplatin.
Kishimoto S; Aoki H; Suzuki R; Inoue M; Fukushima S
Anticancer Res; 2018 Jan; 38(1):247-251. PubMed ID: 29277779
[TBL] [Abstract][Full Text] [Related]
23. Prospective Study of Transcatheter Arterial Chemoembolization (TACE) with Ginsenoside Rg3 versus TACE Alone for the Treatment of Patients with Advanced Hepatocellular Carcinoma.
Zhou B; Yan Z; Liu R; Shi P; Qian S; Qu X; Zhu L; Zhang W; Wang J
Radiology; 2016 Aug; 280(2):630-9. PubMed ID: 26885681
[TBL] [Abstract][Full Text] [Related]
24. Switching the loaded agent from epirubicin to cisplatin: salvage transcatheter arterial chemoembolization with drug-eluting microspheres for unresectable hepatocellular carcinoma.
Seki A; Hori S
Cardiovasc Intervent Radiol; 2012 Jun; 35(3):555-62. PubMed ID: 21562932
[TBL] [Abstract][Full Text] [Related]
25. Warming effect on miriplatin-lipiodol suspension as a chemotherapeutic agent for transarterial chemoembolization for hepatocellular carcinoma: preliminary clinical experience.
Kora S; Urakawa H; Mitsufuji T; Osame A; Higashihara H; Yoshimitsu K
Cardiovasc Intervent Radiol; 2013 Aug; 36(4):1023-9. PubMed ID: 23238851
[TBL] [Abstract][Full Text] [Related]
26. A retrospective comparative study of epirubicin-lipiodol emulsion and cisplatin-lipiodol suspension for use with transcatheter arterial chemoembolization for treatment of hepatocellular carcinoma.
Yodono H; Matsuo K; Shinohara A
Anticancer Drugs; 2011 Mar; 22(3):277-82. PubMed ID: 21360850
[TBL] [Abstract][Full Text] [Related]
27. Transcatheter arterial chemotherapy using miriplatin-lipiodol suspension with or without embolization for unresectable hepatocellular carcinoma.
Imai N; Ikeda K; Kawamura Y; Sezaki H; Hosaka T; Akuta N; Kobayashi M; Saitoh S; Suzuki F; Suzuki Y; Arase Y; Kumada H
Jpn J Clin Oncol; 2012 Mar; 42(3):175-82. PubMed ID: 22210921
[TBL] [Abstract][Full Text] [Related]
28. Safety and efficacy of balloon-occluded transcatheter arterial chemoembolization using miriplatin for hepatocellular carcinoma.
Arai H; Abe T; Takayama H; Toyoda M; Ueno T; Kakizaki S; Sato K
Hepatol Res; 2015 Jun; 45(6):663-6. PubMed ID: 25132539
[TBL] [Abstract][Full Text] [Related]
29. Efficacy of platinum analogue for advanced hepatocellular carcinoma unresponsive to transcatheter arterial chemoembolization with epirubicin.
Kawamura Y; Ikeda K; Hirakawa M; Hosaka T; Kobayashi M; Saitoh S; Yatsuji H; Sezaki H; Akuta N; Suzuki F; Suzuki Y; Arase Y; Kumada H
Hepatol Res; 2009 Apr; 39(4):346-54. PubMed ID: 19054145
[TBL] [Abstract][Full Text] [Related]
30. [Evaluation of transcatheter arterial chemoembolization in the prevention of postoperative recurrence in 1630 patients with hepatocellular carcinoma].
Cheng HY; Xu W; Xu AM; Chen D; Yang YF; Jia YC
Zhonghua Zhong Liu Za Zhi; 2005 Oct; 27(10):626-8. PubMed ID: 16438876
[TBL] [Abstract][Full Text] [Related]
31. Efficacy and safety of cisplatin versus miriplatin in transcatheter arterial chemoembolization and transarterial infusion chemotherapy for hepatocellular carcinoma: A randomized controlled trial.
Otsuji K; Takai K; Nishigaki Y; Shimizu S; Hayashi H; Imai K; Suzuki Y; Hanai T; Ideta T; Miyazaki T; Tomita E; Shimizu M; Moriwaki H
Hepatol Res; 2015 May; 45(5):514-22. PubMed ID: 24961745
[TBL] [Abstract][Full Text] [Related]
32. Usefulness and limitations of balloon-occluded transcatheter arterial chemoembolization using miriplatin for patients with four or fewer hepatocellular carcinoma nodules.
Kawamura Y; Ikeda K; Fujiyama S; Hosaka T; Kobayashi M; Saitoh S; Sezaki H; Akuta N; Suzuki F; Suzuki Y; Arase Y; Kumada H
Hepatol Res; 2017 Mar; 47(4):338-346. PubMed ID: 27249401
[TBL] [Abstract][Full Text] [Related]
33. [Comparison of safety and efficacy for transcatheter arterial chemoembolization alone and plus radiofrequency ablation in the treatment of single branch portal vein tumor thrombus of hepatocellular carcinoma and their prognosis factors].
Zhao M; Wang JP; Li W; Huang ZL; Zhang FJ; Fan WJ; Zhang L; Li XS; Pan CC; Wu PH
Zhonghua Yi Xue Za Zhi; 2011 May; 91(17):1167-72. PubMed ID: 21756768
[TBL] [Abstract][Full Text] [Related]
34. Conventional Versus Small Doxorubicin-eluting Bead Transcatheter Arterial Chemoembolization for Treating Barcelona Clinic Liver Cancer Stage 0/A Hepatocellular Carcinoma.
Kang YJ; Lee BC; Kim JK; Yim NY; Kim HO; Cho SB; Jeong YY
Cardiovasc Intervent Radiol; 2020 Jan; 43(1):55-64. PubMed ID: 31646378
[TBL] [Abstract][Full Text] [Related]
35. Prospective evaluation of transcatheter arterial chemoembolization (TACE) with multiple anti-cancer drugs (epirubicin, cisplatin, mitomycin c, 5-fluorouracil) compared with TACE with epirubicin for treatment of hepatocellular carcinoma.
Sahara S; Kawai N; Sato M; Tanaka T; Ikoma A; Nakata K; Sanda H; Minamiguchi H; Nakai M; Shirai S; Sonomura T
Cardiovasc Intervent Radiol; 2012 Dec; 35(6):1363-71. PubMed ID: 22358993
[TBL] [Abstract][Full Text] [Related]
36. Interventional radiology for advanced hepatocellular carcinoma: comparison of hepatic artery infusion chemotherapy and transcatheter arterial lipiodol chemoembolization.
Sumie S; Yamashita F; Ando E; Tanaka M; Yano Y; Fukumori K; Sata M
AJR Am J Roentgenol; 2003 Nov; 181(5):1327-34. PubMed ID: 14573429
[TBL] [Abstract][Full Text] [Related]
37. Initial safety and outcomes of miriplatin plus low-dose epirubicin for transarterial chemoembolisation of hepatocellular carcinoma.
Iwazawa J; Hashimoto N; Ohue S; Mitani T
Anticancer Res; 2012 Nov; 32(11):5039-44. PubMed ID: 23155276
[TBL] [Abstract][Full Text] [Related]
38. Short-term efficacy of transarterial chemoembolization with epirubicin-loaded superabsorbent polymer microspheres for hepatocellular carcinoma: comparison with conventional transarterial chemoembolization.
Morimoto M; Kobayashi S; Moriya S; Ueno M; Tezuka S; Irie K; Goda Y; Ohkawa S
Abdom Radiol (NY); 2017 Feb; 42(2):612-619. PubMed ID: 27624498
[TBL] [Abstract][Full Text] [Related]
39. Efficacy of transcatheter embolization/chemoembolization (TAE/TACE) for the treatment of single hepatocellular carcinoma.
Miraglia R; Pietrosi G; Maruzzelli L; Petridis I; Caruso S; Marrone G; Mamone G; Vizzini G; Luca A; Gridelli B
World J Gastroenterol; 2007 Jun; 13(21):2952-5. PubMed ID: 17589945
[TBL] [Abstract][Full Text] [Related]
40. [Strategy for advanced hepatocellular carcinoma unresponsive to transcatheter arterial chemoembolization using epirubicin].
Kawamura Y; Ikeda K; Kumada H
Gan To Kagaku Ryoho; 2010 Mar; 37(3):402-7. PubMed ID: 20332675
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
